Buffy the asthma inhaler? Teva taps ‘Vampire Slayer’ actress to raise inhaler misuse awarenessnews2021-09-29T15:33:33+00:00September 29th, 2021|Fierce Pharma|
More trouble for Biocon insulin plant in Malaysia as FDA flags six Form 483 observationsnews2021-09-29T15:17:41+00:00September 29th, 2021|Fierce Pharma|
More trouble for Biocon insulin plant in Malaysia as FDA flags 6 Form 483 observationsnews2021-09-29T15:17:41+00:00September 29th, 2021|Fierce Pharma|
Pfizer’s next-gen Prevnar 20 can be administered with a flu shot, study findsnews2021-09-29T13:47:46+00:00September 29th, 2021|Fierce Pharma|
Does Teva’s $15M, 18-year opioid settlement with Louisiana signal the start of a trend?news2021-09-29T13:43:23+00:00September 29th, 2021|Fierce Pharma|
AbbVie pressures Biohaven in migraine prevention with FDA approval for its CGRP blockbuster-to-be Quliptanews2021-09-29T13:38:02+00:00September 29th, 2021|Fierce Pharma|
In Humira kickbacks case, disgruntled AbbVie investors score class-action statusnews2021-09-28T17:43:30+00:00September 28th, 2021|Fierce Pharma|
Amid new pricing pressure, Lilly cuts cost of generic insulin by another 40%news2021-09-28T13:53:27+00:00September 28th, 2021|Fierce Pharma|
Merck’s reported $11B Acceleron buy could help it diversify beyond Keytruda, but antitrust hurdles loom: analystsnews2021-09-28T13:50:39+00:00September 28th, 2021|Fierce Pharma|
Almac proposes expansion of its Northern Ireland production facility: reportnews2021-09-28T13:24:34+00:00September 28th, 2021|Fierce Pharma|
